Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Aurer · SciRah

Researcher profile · Semantic Scholar

I. Aurer

Share profile

I. Aurer — researcher profile on SciRah

h-index: 26
Works: 224
Citations: 2,381

Most-cited papers

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
A. Younes, P. Hilden, B. Coiffier, A. Hagenbeek +46 more
2017Annals of Oncology335 citations Open access
Semantic Scholar
The Genetic Basis of Hepatosplenic T Cell Lymphoma
Matthew Mckinney, Andrea B. Moffitt, P. Gaulard, M. Travert +52 more
2017Cancer Discovery181 citations Open access
Semantic Scholar
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
P. Carde, M. Karrasch, C. Fortpied, P. Brice +16 more
2016Journal of Clinical Oncology118 citations
Semantic Scholar
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
M. Federico, M. D. Caballero Barrigón, L. Marcheselli, V. Tarantino +24 more
2018The Lancet Haematology104 citations Open access
Semantic Scholar
FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
M. Spina, Z. Nagy, Josep M. Ribera, M. Federico +17 more
2015Annals of Oncology78 citations Open access
Semantic Scholar
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial
L. Fornecker, J. Lazarovici, I. Aurer, R. Casasnovas +21 more
2022Journal of Clinical Oncology72 citations Open access
Semantic Scholar
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network
M. Dreyling, H. Kluin-Nelemans, S. Beá, W. Klapper +16 more
2013Leukemia and Lymphoma61 citations
Semantic Scholar
Bendamustine: A review of pharmacology, clinical use and immunological effects
H. Lalić, I. Aurer, D. Batinić, D. Visnjic +2 more
2022Oncology Report47 citations Open access
Semantic Scholar
A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)
J. Sharman, A. Liberati, K. Ishizawa, Tahira Khan +4 more
2019BioDrugs45 citations Open access
Semantic Scholar
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.
I. Horvat, A. Boban, R. Zadro, M. Antolic +13 more
2019Clinical Lymphoma, Myeloma & Leukemia39 citations
Semantic Scholar
Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study.
I. Radman, Jasminka Kovačević-Metelko, I. Aurer, D. Nemet +7 more
2020Croatian Medical Journal32 citations
Semantic Scholar
Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma
V. Periša, L. Zibar, A. Knezović, Igor Periša +2 more
2017Wiener Klinische Wochenschrift28 citations
Semantic Scholar
Precision medicine in diffuse large B-cell lymphoma: hitting the target
J. Vermaat, S. Pals, A. Younes, M. Dreyling +4 more
2015Haematologica26 citations Open access
Semantic Scholar
Diffuse large B-cell lymphoma and Burkitt lymphoma in adults and children. In: The European Hematology Association roadmap for European hematology research: a consensus document
H. Tilly, I. Aurer, P. Johnson, G. Lenz +4 more
201624 citations Open access
Semantic Scholar
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations
M. Dreyling, I. Aurer, S. Cortelazzo, O. Hermine +9 more
2018Leukemia and Lymphoma23 citations Open access
Semantic Scholar
Unmet needs in the scientific approach to older patients with lymphoma
D. Bron, I. Aurer, M. André, C. Bonnet +7 more
2017Haematologica21 citations Open access
Semantic Scholar
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
M. Dreyling, I. Aurer, M. Federico, M. Jerkeman +5 more
2021HemaSphere17 citations Open access
Semantic Scholar
Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
B. Jakšić, V. Pejsa, Slobodanka Ostojić-Kolonić, I. Kardum-Skelin +9 more
2018Acta Clinica Croatica12 citations Open access
Semantic Scholar
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
Lucia Morello, S. Rattotti, L. Giordano, M. Jerkeman +16 more
2019HemaSphere11 citations Open access
Semantic Scholar
PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup
L. Fornecker, J. Lazarovici, I. Aurer, R. Casasnovas +20 more
201711 citations
Semantic Scholar
Relapse patterns in early‐PET negative, limited‐stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials
V. Fiaccadori, An Neven, C. Fortpied, I. Aurer +9 more
2022British Journal of Haematology10 citations Open access
Semantic Scholar
belinostat In Relapsed Or Refractory Peripheral T-cell Lymphoma (r/r Ptcl) Subtype Angioimmunoblastic T-cell Lymphoma (aitl): Results From The Pivotal Belief Trial : 153
S. Horwitz, O. O'Connor, W. Jurczak, A. van Hoof +16 more
201310 citations
Semantic Scholar
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience
S. Bašić-Kinda, I. Radman, D. Dujmović, Ivana Ilić +8 more
2020Annals of Hematology9 citations
Semantic Scholar
Comparison of the Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Glasgow Prognostic Score in Diffuse Large B-Cell Lymphoma
V. Periša, A. Knezović, L. Zibar, J. Sinčić-Petričević +3 more
20169 citations Open access
Semantic Scholar
Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant
S. Bašić-Kinda, N. Duraković, S. Dotlic, Ranka Serventi Seiwerth +3 more
2013Leukemia and Lymphoma9 citations
Semantic Scholar
Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2
S. Perković, S. Bašić-Kinda, V. Gašparović, Ž. Krznarić +4 more
2012Hematology Reports9 citations Open access
Semantic Scholar
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
S. Alonso-Álvarez, M. Manni, S. Montoto, C. Sarkozy +17 more
2021European Journal of Cancer8 citations Open access
Semantic Scholar
GINGIVAL ULCERATIONS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A case report and literature review
Vanja Vucicevic Boras, Danica Vidović Juras, I. Aurer, S. Bašić-Kinda +1 more
2019Acta Clinica Croatica8 citations Open access
Semantic Scholar
Multiparameter flow cytometry is necessary for detection, characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms
S. Perković, S. Bašić-Kinda, I. Aurer, I. Ugrina +3 more
2013International journal of hematology8 citations
Semantic Scholar
High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone
S. Bašić-Kinda, Ivan Karlak, N. Duraković, Z. Lubina +5 more
2018Internal medicine journal (Print)7 citations
Semantic Scholar
Tackling Mantle Cell Lymphoma in Europe
D. Horgan, J. Walewski, I. Aurer, C. Visco +6 more
2022Healthcare6 citations Open access
Semantic Scholar
The EHA Research Roadmap: Malignant Lymphoid Diseases
M. Dreyling, M. André, N. Gokbuget, H. Tilly +50 more
2022HemaSphere5 citations Open access
Semantic Scholar
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
D. Galušić, S. Bašić-Kinda, A. Pijuk, V. Milunović +8 more
2022HemaSphere5 citations Open access
Semantic Scholar
[Lymphoma diagnosis and treatment - second Croatian consensus].
I. Aurer, S. Gašparov, M. Kralik, A. Balenović +6 more
2013Liječnički vjesnik5 citations
Semantic Scholar
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience
Lea Galunic Bilic, F. Šantek, J. Grah, S. Bašić-Kinda +6 more
2023La radiologia medica4 citations
Semantic Scholar
Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
I. Aurer, M. Dreyling, M. Federico, H. Tilly +4 more
2020HemaSphere4 citations Open access
Semantic Scholar
Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia
I. Radman, M. Vodanović, Inga Mandac Rogulj, J. Roganović +6 more
2019Liječnički vjesnik4 citations Open access
Semantic Scholar
Serum chitotriosidase: a circulating biomarker in polycythemia vera
I. Krečak, V. Gverić-Krečak, P. Rončević, S. Bašić-Kinda +11 more
2018Hematology4 citations Open access
Semantic Scholar
The appropriateness of platelet transfusions in hematological patients and the potential for improvement.
Milica Liker, S. Bašić-Kinda, N. Duraković, I. Bojanić +2 more
2022Transfusion Clinique et Biologique3 citations
Semantic Scholar
RELAPSES IN INTERIM PET NEGATIVE LIMITED STAGE HODGKIN LYMPHOMA PATIENTS RECEIVING ABVD WITH OR WITHOUT RADIOTHERAPY–ANALYSIS OF EORTC/FIL/LYSA H10 AND UK NCRI RAPID TRIALS
I. Aurer, An Neven, V. Fiaccadori, N. Counsell +9 more
2021Hematological Oncology3 citations Open access
Semantic Scholar
OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA
A. Gac, L. Chartier, T. Girinsky, M. Gotti +12 more
2019Hematological Oncology3 citations
Semantic Scholar
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma
I. Aurer, D. Nemet, Z. Mitrović, D. Dujmović +8 more
2016Annals of Hematology3 citations
Semantic Scholar
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE
Sveučilište U. Zagrebu, Medicinski Fakultet, D. Dujmović, Izvanstanična Cirkulirajuća +7 more
20143 citations
Semantic Scholar
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma
V. Premužić, S. Bašić-Kinda, I. Radman, D. Dujmović +9 more
2023Medicine2 citations Open access
Semantic Scholar
Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases
I. Aurer, O. Jakšić, S. Bašić-Kinda, S. Mrdenovic +10 more
2021Blood2 citations Open access
Semantic Scholar
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
S. Bašić-Kinda, Karla Mišura Jakobac, J. Sinčić-Petričević, D. Deak +9 more
2021Croatian Medical Journal2 citations Open access
Semantic Scholar
BASELINE MAXIMUM TUMOUR DIAMETER IS ASSOCIATED WITH EVENT‐FREE SURVIVAL FOR PET‐NEGATIVE PATIENTS WITH LIMITED‐STAGE HODGKIN LYMPHOMA: ANALYSIS OF THE H10 AND RAPID TRIALS
E. Phillips, N. Counsell, T. Illidge, M. André +9 more
2021Hematological Oncology2 citations Open access
Semantic Scholar
Comparison of Different Schedules of Rituximab and Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of Krohem
S. Bašić-Kinda, I. Hude, Ena Ranković, Slobodanka Ostojić-Kolonić +7 more
2021Journal of Cancer Science and Clinical Therapeutics2 citations Open access
Semantic Scholar
Using both clinical research and population-based cancer registry in long-term research- a case study using EORTC trials and the Dutch national cancer registry (IKNL)
Li-Fang Liu, An Neven, F. Giusti, M. Maraldo +5 more
2020Journal of Cancer Policy2 citations
Semantic Scholar
Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
I. Aurer, N. Zing, M. Federico
2020HemaSphere2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Bašić-Kinda×18
Invite
S. Bašić-Kinda — researcher profile on SciRah
M. Federico×12
Invite
M. Federico — researcher profile on SciRah
M. Dreyling×8
Invite
M. Dreyling — researcher profile on SciRah
M. André×8
Invite
M. André — researcher profile on SciRah

×7

Invite

C. Fortpied — researcher profile on SciRah

Invite

I. Radman — researcher profile on SciRah

M. Vodanović×6

Invite

M. Vodanović — researcher profile on SciRah

N. Duraković×5

Invite

N. Duraković — researcher profile on SciRah

J. Sinčić-Petričević×5

Invite

J. Sinčić-Petričević — researcher profile on SciRah

Invite

M. Jerkeman — researcher profile on SciRah

Invite

V. Pejsa — researcher profile on SciRah

D. Dujmović×5

Invite

D. Dujmović — researcher profile on SciRah